-
Add to Cart The item has been addedC647897-50mgCPA inhibitor (Carboxypeptidase inhibitor: compound 5) is a potent carboxypeptidase A (CPA) inhibitor with a K i of 0.32 μMForm:SolidIC50&: Target:Ki: 0.32 μM (CPA). -
Add to Cart The item has been addedC647897-5mgCPA inhibitor (Carboxypeptidase inhibitor: compound 5) is a potent carboxypeptidase A (CPA) inhibitor with a K i of 0.32 μMForm:SolidIC50&: Target:Ki: 0.32 μM (CPA). -
Add to Cart The item has been addedC655212-1mlCPA inhibitor (Carboxypeptidase inhibitor: compound 5) is a potent carboxypeptidase A (CPA) inhibitor with a K i of 0.32 μMIC50&: Target:Ki: 0.32 μM (CPA). -
Add to Cart The item has been addedC646560-100mgCPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC 50 of 8.1 nM for EP300 HAT . CPI-1612 has an anticancer activityIn VitroCPI-1612 inhibits full length EP300 and full length CBP with IC 50 -
Add to Cart The item has been addedC646560-10mgCPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC 50 of 8.1 nM for EP300 HAT . CPI-1612 has an anticancer activityIn VitroCPI-1612 inhibits full length EP300 and full length CBP with IC 50 -
Add to Cart The item has been addedC646560-25mgCPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC 50 of 8.1 nM for EP300 HAT . CPI-1612 has an anticancer activityIn VitroCPI-1612 inhibits full length EP300 and full length CBP with IC 50 -
Add to Cart The item has been addedC646560-50mgCPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC 50 of 8.1 nM for EP300 HAT . CPI-1612 has an anticancer activityIn VitroCPI-1612 inhibits full length EP300 and full length CBP with IC 50 -
Add to Cart The item has been addedC646560-5mgCPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC 50 of 8.1 nM for EP300 HAT . CPI-1612 has an anticancer activityIn VitroCPI-1612 inhibits full length EP300 and full length CBP with IC 50 -
Add to Cart The item has been addedC647333-100mgCPI-455 is a specific, pan- KDM5 inhibitor with an IC 50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models -
Add to Cart The item has been addedC647333-10mgCPI-455 is a specific, pan- KDM5 inhibitor with an IC 50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models -
Add to Cart The item has been addedC647333-1mgCPI-455 is a specific, pan- KDM5 inhibitor with an IC 50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models -
Add to Cart The item has been addedC647333-25mgCPI-455 is a specific, pan- KDM5 inhibitor with an IC 50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models
